Interactions in cancer treatment considering cancer therapy, concomitant medications, food, herbal medicine and other supplements

Prognostic impact of polypharmacy and drug interactions in patients with advanced cancer

(2019) Alexander Hoemme et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Cancer patients’ use of complementary and alternative medicine in Sweden: a cross-sectional study

(2019) Kathrin Wode et al.   BMC Complementary and Alternative Medicine

Prevalence of potential drug–drug interactions in outpatients on treatment with parenteral antineoplastic drugs

(2019) M. Castro-Manzanares et al.   International Journal of Clinical Pharmacy

Food Sources of Potassium in the Average Polish Diet

(2019) Hanna Górska-Warsewicz et al.   Nutrients

Potential Interactions of Medication Prescribed in Discharge Letters from a Clinic for Hematology and Oncology

(2018) Louisa Schaefer et al.   Oncology Research and Treatment

The effect of ferrous ions, calcium ions and citric acid on absorption of ciprofloxacin across caco-2 cells: practical and structural approach

(2018) Dina El-Sabawi et al.   DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY

Long-Term Effects of Spironolactone on Kidney Function and Hyperkalemia-Associated Hospitalization in Patients with Chronic Kidney Disease

(2018) Chen-Ta Yang et al.   Journal of Clinical Medicine

An assessment of the impact of herb-drug combinations used by cancer patients

(2016) Saud M. Alsanad et al.   BMC Complementary and Alternative Medicine

Hepatotoxicity by Dietary Supplements: A Tabular Listing and Clinical Characteristics

(2016) Miren García-Cortés et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Pharmacokinetic Interactions of Herbs with Cytochrome P450 and P-Glycoprotein

(2015) Hyun-Jong Cho et al.   Evidence-based Complementary and Alternative Medicine

Risk of hyperkalemia and combined use of spironolactone and long-term ACE inhibitor/angiotensin receptor blocker therapy in heart failure using real-life data: a population- and insurance-based cohort

(2015) Sascha Abbas et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Estimation of the binding modes with important human cytochrome P450 enzymes, drug interaction potential, pharmacokinetics, and hepatotoxicity of ginger components using molecular docking, computational, and pharmacokinetic modeling studies

(2015) Shu-Feng Zhou et al.   Drug Design Development and Therapy

Grapefruit-medication interactions: Forbidden fruit or avoidable consequences?

(2012) D. G. Bailey et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

Potential interactions of complementary and alternative medicine with cancer therapy in outpatients with gynecological cancer in a comprehensive cancer center

(2012) T. Zeller et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Unawareness of the Effects of Soy Intake on the Management of Congenital Hypothyroidism

(2012) A. G. Fruzza et al.   PEDIATRICS

Prevalence of complementary medicine use in a phase 1 clinical trials program

(2011) Aung Naing et al.   CANCER

Effects of Mace and Nutmeg on Human Cytochrome P450 3A4 and 2C9 Activity

(2010) Yuka Kimura et al.   BIOLOGICAL & PHARMACEUTICAL BULLETIN

Proton Pump Inhibitor-Induced Neutropenia

(2010) Aurore Gouraud et al.   CLINICAL DRUG INVESTIGATION

Effects of epigallocatechin gallate on the oral bioavailability and pharmacokinetics of tamoxifen and its main metabolite, 4-hydroxytamoxifen, in rats

(2009) Sang-Chul Shin et al.   ANTI-CANCER DRUGS

Effects of oral epigallocatechin gallate on the oral pharmacokinetics of verapamil in rats

(2009) Joong-Hwa Chung et al.   BIOPHARMACEUTICS & DRUG DISPOSITION

Green tea polyphenols block the anticancer effects of bortezomib and other boronic acid-based proteasome inhibitors

(2009) E. B. Golden et al.   BLOOD

Bortezomib and EGCG: no green tea for you?

(2009) J. J. Shah et al.   BLOOD

Hepatotoxicity from green tea: a review of the literature and two unpublished cases

(2009) Gabriela Mazzanti et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Ascorbic acid inhibits antitumor activity of bortezomib in vivo

(2009) G Perrone et al.   LEUKEMIA

In vitroinhibition of CYP3A4 by herbal remedies frequently used by cancer patients

(2009) Silje Engdal et al.   PHYTOTHERAPY RESEARCH

Vitamin C Antagonizes the Cytotoxic Effects of Antineoplastic Drugs

(2008) M. L. Heaney et al.   CANCER RESEARCH

Medikamentös induzierte Verlängerung des QT-Intervalls

(2008) David Altmann et al.   WIENER KLINISCHE WOCHENSCHRIFT